Evidence map›Paper›PMID 22643849›Full record

ArticleMucosal immunology2012

Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection.

N R Klatt, J D Estes, X Sun, A M Ortiz, J S Barber, L D Harris, B Cervasi, L K Yokomizo, L Pan, C L Vinton and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Mucosal immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 3 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 3 syntheses or guidelines pooled it, 193 citations in OpenAlex.

  1. Pooled it
  2. The Hitchhiker Guide to CD4Frontiers in immunology · 2021
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Maintenance of intestinal CX3CR1Nature communications · 2026
    Article
  7. Observational
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 1 country.

N R KlattLaboratory of Molecular Microbiology and Program in Barrier Immunity and Repair, National Institute of Allergy and Infectious Diseases/ NIH, Bethesda, MD 20892, USA.
J D Estes
X Sun
A M Ortiz
J S Barber
L D Harris
B Cervasi
L K Yokomizo
L Pan
C L Vinton
B Tabb
L A Canary
Q Dang
V M Hirsch
G Alter
Y Belkaid
J D Lifson
G Silvestri
J D Milner
M Paiardini
E K Haddad
J M Brenchley
National Institutes of Health · USEmory University · USFrederick National Laboratory for Cancer Research · USNational Institute of Allergy and Infectious Diseases · USVaccine & Gene Therapy Institute of Florida · USHarvard University · USUniversity of Pennsylvania · USVaccine and Gene Therapy Institute

Funding

Mechanisms of Immune Activation and Disease Progression in Animal ModelsZIAAI001029 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BRENCHLEY, JASON · 2009 to 2025
$28.2M
Pathogenesis Studies Of Simian Immunodeficiency Virus Infection Of MonkeysZIAAI000370 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HIRSCH, VANESSA M. · 2009 to 2022
$16.2M
Pathogenesis and Treatment of Atopic DermatitisZIAAI001098 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MILNER, JOSHUA · 2009 to 2019
$6.5M
Role of Tissue-Specific Factors in the Control of ImmunityZIAAI001132 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BELKAID, YASMINE · 2011 to 2025
$6.4M
Role of Vitamins in the Control of ImmunityZIAAI001133 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BELKAID, YASMINE · 2010 to 2025
$6.1M
TH17 cells in AIDS pathogenesis and HIV vaccinesR01AI084836 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI PAIARDINI, MIRKO · 2009 to 2013
$2.4M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS Z99 AI999999Intramural NIH HHS ZIA AI001029NCI NIH HHS HHSN261200800001ENIAID NIH HHS R01 AI-084836NIAID NIH HHS R01 AI084836
6 · The paper itself

Abstract

Human immunodeficiency virus (HIV) and Simian immunodeficiency virus (SIV) disease progression is associated with multifocal damage to the gastrointestinal tract epithelial barrier that correlates with microbial translocation and persistent pathological immune activation, but the underlying mechanisms remain unclear. Investigating alterations in mucosal immunity during SIV infection, we found that damage to the colonic epithelial barrier was associated with loss of multiple lineages of interleukin (IL)-17-producing lymphocytes, cells that microarray analysis showed expressed genes important for enterocyte homeostasis, including IL-22. IL-22-producing lymphocytes were also lost after SIV infection. Potentially explaining coordinate loss of these distinct populations, we also observed loss of CD103+ dendritic cells (DCs) after SIV infection, which associated with the loss of IL-17- and IL-22-producing lymphocytes. CD103+ DCs expressed genes associated with promotion of IL-17/IL-22+ cells, and coculture of CD103+ DCs and naïve T cells led to increased IL17A and RORc expression in differentiating T cells. These results reveal complex interactions between mucosal immune cell subsets providing potential mechanistic insights into mechanisms of mucosal immune dysregulation during HIV/SIV infection, and offer hints for development of novel therapeutic strategies to address this aspect of AIDS virus pathogenesis.

Indexed as

Immunity, MucosalAnimalsAntigens, CDCell DifferentiationCell LineageCoculture TechniquesColonDendritic CellsEnterocytesGene Expression RegulationIntegrin alpha ChainsInterleukin-17Interleukin-22InterleukinsMacaca mulattaNuclear Receptor Subfamily 1, Group F, Member 3alpha E integrinsAntigens, CDIntegrin alpha ChainsInterleukin-17Interleukin-22InterleukinsNuclear Receptor Subfamily 1, Group F, Member 3

Identifiers

PMID22643849
PMCPMC3443541
OpenAlexW2020122175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.